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Abstract  Perfusion  MRI  of  the  female  pelvis  is  based  on  a  T1-weighted  imaging  acquired
repeatedly at  high  temporal  resolution.  Post-processing  can  be  carried  out  either  from  a  visual
analysis, by  description  of  the  curves  or  by  compartmental  modeling.  Many  studies  have  shown
this method  to  be  useful  in  detecting  cervical  cancers  (initial  tumor  or  identiﬁcation  of  recur-
rence), and  in  staging  endometrial  cancers  (assessment  of  cervical  invasion).  More  recent
studies have  described  perfusion  MRI  as  a  tool  for  characterizing  adnexal  tumors  based  on
the properties  of  the  microvascular  wall.  When  it  is  combined  with  morphological  MRI  ﬁndings
and diffusion  sequences,  it  incorporates  a  decision-making  algorithm  which  has  a  diagnostic
performance  of  95.4%  in  characterizing  complex  adnexal  masses  (Thomassin-Naggara  et  al.,
2011).
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
‘‘Contrast  enhanced’’  Magnetic  Resonance  Imaging  (MRI)  has  advanced  because  of  per-
fusion,  blood  volume  and  capillary  permeability  which  depend  on  the  quality  of  the  vascular
walls.  MRI  therefore  offers  an  in  vivo  functional  examination,  providing  information  on  the
structure  and  function  of  the  tumor  microvasculature.  Many  MRI  techniques  are  used  to
study  angiogenesis:  with  endogenous  contrast  (the  BOLD  effect,  or  spin  labeling)  or  using
an  exogenous  contrast  medium  (gadolinium  chelates,  which  diffuse  into  the  extracellu-
lar  space  and  more  recently,  long  lasting  vascular  gadolinium  macromolecules,  SPIO  and
USPIO).  In  pelvic  imaging,  dynamic  contrast  studies  are  performed  mostly  in  a  T1-weighted
sequence  because  of  the  poorer  spatial  resolution  of  techniques  such  as  spin  labeling  or
the  BOLD  effect.
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The  educational  aims  of  this  review  are  to  describe  the
equences  and  post-processing  which  can  be  used  in  contrast
nhanced  dynamic  imaging  in  the  female  pelvis,  to  consider
he  used  of  dynamic  contrast  enhanced  MRI  in  uterine  dis-
ases  and  to  characterize  adnexal  tumors  and  to  incorporate
hese  ﬁndings  into  usual  practice  to  determine  the  added
alue  of  this  MRI  mode  in  clinical  diagnostics.
ypes of dynamic contrast enhanced MRI
equences after data processing
equences
eneral  details
‘The  best  sequence  would  be  one  which  achieves  the  best
ompromise  between  good  spatial  resolution  and  good  tem-
oral  resolution’’.  Most  studies  in  pelvic  imaging  deﬁne
iagnostic  criteria  based  on  changes  in  contrast  enhance-
ent  in  the  ﬁrst  two  minutes  after  injection,  with  a
emporal  resolution  of  under  15  s.  Because  of  this  time
onstraint,  it  is  not  always  possible  to  investigate  a large
olume,  as  may  be  necessary  in  adnexal  disease,  to  give  an
xample.  In  addition,  dynamic  contrast  enhanced  MRI  must
ffer  good  spatial  resolution  in  order  to  enable  a  detailed
nalysis  of  the  extension  of  endometrial  cancer  or  assess-
ent  of  contrast  enhancement  of  small  growths  in  adnexal
umors.
When  machine  performances  permit,  the  optimal
equence  is  therefore  an  isotropic  3D  gradient  echo
equence  in  order  to  enable  multiplanar  reconstructions  to
e  made,  covering  a  sufﬁcient  volume  to  be  independent  of
he  initial  analysis  of  morphological  sequences.  In  practice,
f  this  type  of  sequence  does  not  provide  a  temporal  reso-
ution  of  under  15  s,  the  alternative  is  to  use  a  2D  gradient
cho  sequence  and  an  acquisition  plane  containing  the  struc-
ure  to  be  examined  and  the  internal  reference  point  (for
xample,  the  adjacent  myometrium  in  the  investigation
f  adnexal  tumors)  on  gadolinium-enhanced  morphological
equences.
Dynamic  gadolinium  contrast  studies  should  be  as  repro-
ucible  as  possible  and  are  therefore  ideally  performed  with
n  automated  injector  using  a  dose  of  0.01  mmol/kg  of  con-
rast  rinsed  with  20  cc  of  physiological  saline.
peciﬁc  features  depending  on  the  organ  being
xamined
n  our  clinical  practice,  we  use  a  2D  T1-weighted  echo  gra-
ient  sequence  (FLASH  2D)  with  the  following  parameters
RT/ET:  27/2.24  ms;  ﬂip  angle:  80◦;  section  thickness:  5  mm;
umber  of  sections:  3;  excitations:  1;  FOV:  400—200  mm  and
atrix:  256  ×  134;  BW:  300).
Upper  and  lower  saturation  bands  are  positioned  on
ither  side  of  the  acquisition  box  to  limit  inﬂow  effect  and
enous  ﬂow  artifacts.
In  order  to  study  the  uterus,  the  dynamic  contrast
nhanced  MRI  sequences  should  preferably  be  positioned
nd  acquired  in  the  sagittal  plane  in  order  to  visualize  the
hole  endometrial-myometrial  interface.
To  study  the  adenexae,  we  position  the  section  box  in
rder  to  acquire  both  the  solid  component  of  the  adnexal
D
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umor  and  the  adjacent  external  myometrium.  The  box  may
herefore  range  in  position  from  being  strictly  axial  to  coro-
al,  including  all  types  of  oblique  axial  planes.
rocessed data analysis and limitations of
cquisitions
nalysis  of  enhancement  kinetics
everal  enhancement  kinetic  analyses  are  possible  for  T1-
eighted  gadolinium  dynamic  contrast  enhanced  MRI  (DCE-
RI):
the  simplest  method  involves  describing  the  shapes  of
the  enhancement  curves,  which  may  or  may  not  be  com-
pared  to  the  enhancement  curve  of  the  reference  organ
[1].  For  pelvic  imaging,  some  authors  have  proposed  using
the  striated  pelvic  wall  muscles  as  the  internal  reference.
In  our  opinion,  this  tissue  is  a poor  reference  point.  In
order  for  a  tissue  to  be  a  good  reference,  it  should  lie
within  the  study  ﬁeld,  have  consistent  perfusion  in  differ-
ent  people  (variations  in  muscle  perfusion  in  correlation
with  muscular  atrophy  can  be  observed)  and  the  enhance-
ment  of  the  reference  tissue  should  be  similar  to  that  of
the  tissue  being  examined  (this  does  not  apply  to  striated
muscle  which  has  very  low  enhancement).  In  our  experi-
ence,  the  external  myometrium  fulﬁlls  two  of  these  three
conditions  satisfactorily.  It  is  located  close  to  the  pelvic
organs  and  has  a  similar  enhancement  curve  to  that  of  the
endometrium  or  the  solid  part  of  ovarian  tumors.  On  the
other  hand,  there  are  signiﬁcant  differences  in  all  of  the
perfusion  parameters  depending  on  hormone  status,  all  of
them  declining  at  the  menopause  [2].  This  must  be  taken
into  account  when  enhancement  curves  are  examined;
the  second  form  of  processed  data  analysis  involves
adjusting  the  enhancement  curve  using  a  mathematical
equation  which  contains  parameters  describing  the  curve,
such  as  the  asymptote,  the  ascension  half  time,  the  max-
imum  gradient  and  the  area  under  the  curve.  The  area
under  the  enhancement  curve  is  considered  to  be  the
most  robust  parameter  and  is  often  used  in  longitudinal
studies  examining  the  efﬁcacy  of  medicinal  products  on
tumors.  These  are  more  reproducible  parameters  than  a
simple  description  of  the  enhancement  curve  but  are  still
based  on  signal  values  which  are  always  dependent  on
the  conditions  of  the  acquisition  (differences  in  radiofre-
quency  wave,  gain,  settings  for  the  sequence  used  [TR,
TE,  tilt  angle]).  The  reference  analytical  method  for
perfusion  MRI  is  therefore  quantiﬁcation  of  the  concen-
tration  of  contrast  medium  in  the  tissue  compartments
and  exchanges  of  contrast  medium  between  compart-
ments  (or  compartmental  modeling).  This  is  the  reference
method  for  analysis  of  dynamic  contrast  enhanced  MRI
as  it  allows  reproducible  parameters  to  be  calculated  on
different  machines.  It  also  enables  a  pathophysiological
interpretation  of  tumor  enhancement  to  be  made,  with
a  reliable  analysis  of  perfusion  effects.  To  achieve  this
quantiﬁcation,  the  acquisitions  must  be  clariﬁed  and  post-
processing  of  the  data  obtained  must  be  carried  out.ata  acquisition
n  MRI  sequence  has  been  developed  for  pelvic  imag-
ng  which  combines  the  high  spatial  resolution  (needed  to
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identify  small  tissue  structures  such  as  growths  in  adnexal
disease)  with  high  temporal  resolution  (in  the  region  of
3  s)  (the  turbo-FLASH  sequence).  This  allows  each  patient’s
speciﬁc  arterial  input  function  to  be  used  (the  criteria  for
post-processing  quality).  In  addition,  the  tilt  angle  has  been
optimized:  using  high  tilt  angles  (80◦)  reduces  the  blood  sig-
nal  saturation  and  optimizes  the  enhancement  dynamics  and
linearity  of  the  relationship  between  signal  and  gadolinium
concentration.
Post-processing
Semi-automatic  ﬁltering  methods  for  dynamic  contrast
enhanced  MRI  ﬁndings  are  useful  for  improving  the  acqui-
sition  signal  to  noise  ratio  both  qualitatively  (by  visual
examination)  and  quantitatively  (post-processing  of  data).
This  method  is  particularly  useful  to  map  parameters  and
provides  a  less  biased  analysis  than  mapping  the  regions  of
interest.
In  addition,  a  comparison  of  different  pharmacokinetic
models  has  shown  that  four  parameter  compartmental  mod-
elings  (the  most  detailed  compartmental  model  allowing
tissue  perfusion  (TP),  the  blood  volume  fraction  (Vb),  capil-
lary  surface  permeability  (SP)  and  interstitial  volume  (eV))
to  be  calculated.  This  provides  the  most  reliable  description
of  physiological  effects  and  optimally  uses  the  information
contained  in  data  acquired  via  pelvic  imaging.  Software  is
beginning  to  emerge  to  extend  the  use  of  this  type  of  anal-
ysis,  particularly  to  study  breast  tissue  perfusion  (extended
Tofts-Kéty  modeling)  and  prostate  (Brix  model).  However,
this  type  of  analysis  is  still  experimental  in  pelvic  gynecol-
ogy.
Uterus
Healthy myometrium
The  ﬁrst  description  of  healthy  myometrial  enhancement  on
dynamic  contrast  enhanced  MRI  was  reported  by  Yamashita
et  al.  in  1993  [3].  This  landmark  study  described  three
types  of  myometrial  behavior  depending  on  hormone  sta-
tus  and  time  of  the  cycle.  Type  1  enhancement  involved
early  uptake  in  the  sub-endometrial  ‘‘halo’’,  the  ﬁne  line
of  enhancement  located  between  the  endometrium  and  the
myometrium.  This  was  seen  more  often  in  patients  during
the  proliferative  phase  of  the  cycle  and  in  post-menopausal
patients.  Type  2  enhancement  involved  early  uptake  in  the
junctional  zone  (a  thick  enhancement  line)  which  represents
the  internal  myometrial  band  appearing  as  a  hypointensity
on  T2-weighted  sequences.  Thirdly,  type  3  enhancement  was
early  uptake  in  whole  myometrium,  particularly  the  exter-
nal  portion.  These  latter  two  types  of  enhancement  were
seen  more  often  in  the  luteal  and  menstrual  phases  of  the
cycle.  A  key  point  of  this  study  was  that  it  was  the  ﬁrst
to  describe  the  types  of  enhancement  seen  in  the  healthy
myometrium  although  it  was  only  carried  out  in  a  popula-
tion  of  13  patients.  In  a  study  carried  out  by  our  group  on
85  patients  including  23  who  were  post-menopausal  and  62
who  were  pre-menopausal  (31  in  the  proliferative  phase  and
31  in  the  luteal  phase),  we  found  behavioral  differences  in
healthy  myometrium  on  dynamic  contrast  enhanced  MRI.
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he  post-menopausal  patients  had  identical  internal  and
xternal  myometrial  enhancement  which  was  signiﬁcantly
ess  intense  than  in  the  pre-menopausal  patients.  Internal
yometrial  enhancement  occurred  earlier  and  was  more
ntense  in  the  proliferative  than  in  the  luteal  phase  of  the
ycle.  Doppler  ultrasound  differences  in  internal  myometrial
nfusion  during  the  menstrual  cycle  are  well  described  [4]
nd  are  believed  to  be  involved  in  migration  of  spermatozoa
contraction)  and  in  implantation.  The  consistent  ﬁndings
btained  with  Doppler  ultrasound  and  dynamic  contrast
nhanced  MRI  has  opened  many  areas  for  applications  in
isease  and  fertility.
terine tumors
ndometrium
amashita’s  landmark  article  was  intended  to  provide  the
rst  description  of  the  use  of  dynamic  contrast  enhanced  MRI
o  assess  endometrial  cancers.  Tumor  gadolinium  enhance-
ent  was  less  than  that  of  the  myometrium  in  the  early
hase  in  most  cases  (80%)  and  tended  to  increase  in  the  later
equences  but  remained  hypointense  in  70%  of  patients,
sointense  in  20%  and  occasionally  hyperintense  compared
o  the  myometrium  (in  10%  of  cases)  [5].  Myometrial  exten-
ion  can  be  easily  assessed  on  T2-weighted  sequences  in
re-menopausal  patients  in  whom  the  junctional  zone  is
raditionally  clearly  seen.  This  zone,  however,  changes  in
esponse  to  hormones.  T2-weighted  sequences  to  assess
yometrial  extension  have  a  diagnostic  accuracy  of  80%
n  pre-menopausal  patients  compared  to  only  33%  in  post-
enopausal  women.  This  landmark  study  was  conducted
sing  the  old  FIGO  classiﬁcation  which  made  three  distinc-
ions  within  stage  1:  the  former  stages  IA,  which  was  strictly
ithin  the  endometrium  from  stages  IB  with  myometrial
nvasion  of  under  50%  and  stages  IC  with  myometrial  inva-
ion  of  over  50%.  The  FIGO  classiﬁcation  has  now  changed
6]  and  stages  IA  and  IB  are  now  merged.  The  radiolo-
ist  now  only  has  one  question  about  stage  I to  answer:  is
yometrial  invasion  over  or  below  50%?  The  importance  of
nding  an  interruption  in  the  periendometrial  halo,  previ-
usly  described  as  the  key  sign  of  myometrial  invasion  and
btained  on  perfusion  sequences,  is  no  longer  important.
ne  study  compared  the  value  of  T2-weighted,  diffusion
nd  perfusion  MRI  to  assess  myometrial  invasion  in  endome-
rial  cancer  [7]  and  showed  that  merged  T2-weighted  and
iffusion  sequences  were  signiﬁcantly  superior  for  tumors
ith  under  50%  myometrial  invasion  compared  to  perfusion
equences  alone.  This  improvement  in  performance  has
een  conﬁrmed  in  a  more  recent  study  in  terms  of  ana-
ytical  reproducibility,  with  a  Kappa  coefﬁcient  of  0.25  for
erfusion  MRI  compared  to  0.75  for  diffusion  [8]  (Fig.  1).
adolinium  dynamic  contrast  enhanced  MRI  is  still  useful  if
ervical  extension  is  suspected  because  of  the  poor  physio-
ogical  vascularization  of  the  cervical  stroma.  In  addition,
ome  authors  have  demonstrated  that  dynamic  contrast
nhanced  MRI  is  useful  in  distinguishing  benign  disease  from
ndometrial  cancer.  The  technique  is  useful  when  diagnostic
ysteroscopy  and  biopsy  cannot  be  performed  or  is  non-
ontributory  (cervical  stenosis,  bulky  submucosal  ﬁbroids,
denomyosis,  etc.).
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Figure 1. Comparison of T2-weighted perfusion and diffusion MRI to assess myometrial invasion of an endometrial cancer. The contrast
between the tumor growing in the endometrial cavity and the adjacent myometrium is far more pronounced on the diffusion sequences
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F
t
vhan on the T2-weighted or perfusion sequences.
ervix
ervical  cancer  appears  as  an  isointense  mass  on
2-weighted  sequences,  interrupting  the  physiological
ypointense  signal  of  the  cervical  ﬁbrous  stroma.  The
umor  is  generally  well  deﬁned  on  T2-weighted  sequences
ut  can  be  difﬁcult  to  detect  if  it  is  small.  Dynamic
ontrast  enhanced  MRI  can  be  useful  in  this  situ-
tion  as  cervical  tumors  typically  enhance  intensely
nd  early  (30  s)  after  gadolinium  injection  (Fig.  2).
he  sensitivity  of  dynamic  sequences  to  detect  tumors
as  been  reported  to  be  78%  compared  to  61%  for
2-weighted  sequences  and  39%  for  late  T1-weighted
equences  [5].  The  enhancement  is  inside  the  tumor
nd  is  increased  by  inﬂammation  of  the  normal  adja-
ent  stroma  around  the  tumor.  Measurements  of  tumor
olume  are  not  therefore  recommended  on  dynamic  con-
rast  enhanced  sequences.  In  addition,  dynamic  contrast
nhanced  sequences  are  reported  to  enable  an  assess-
ent  to  be  made  of  tumor  microcirculation,  a  key
d
o
t
igure 2. Comparison of conventional enhanced T2-weighted MRI and 
he tumor on the conventionally enhanced T2-weighted sequences, wher
ery easily on the early dynamic sequences taken 30 s after injection.actor  in  predicting  response  to  radiotherapy:  tumors  with
assive  enhancement  are  those  with  high  perfusion  and  are
herefore  those  which  are  best  controlled  locally  by  radio-
herapy.
Dynamic  contrast  enhanced  MRI  is  useful  in  monitoring
atients  on  treatment  to  distinguish  post-radiation  inﬂam-
ation  from  residual  tumor.  This  is  an  essential  factor  in
eciding  on  curative  surgery  [9].
re- and post-embolization assessment for
terine ﬁbroids
everal  groups  use  dynamic  contrast  enhanced  MRI  in  the
nitial  pre-embolization  assessment.  Fibroids  which  show
ntense  early  enhancement  respond  best  to  embolizationuring  follow-up  is  reported  to  predict  the  effectiveness
f  treatment,  with  an  early  fall  in  perfusion  parameters  in
reated  ﬁbroids  [10].
perfusion MRI to detect cervical cancer. It is difﬁcult to distinguish
eas intense early cervical tumor enhancement enables it to be seen
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Appendix
Normal ovaries and functional disease
The  normal  ovary  displays  intense  early  enhancement  with  a
secondary  washout.  The  enhancement  proﬁle  varies  accord-
ing  to  hormone  status  and  phase  of  the  menstrual  cycle.
The  time  to  peak  has  been  reported  to  be  reduced  together
with  an  increase  in  signal  intensity  at  30  s  and  an  increase
in  secondary  washout  in  patients  with  polycystic  ovarian
syndrome.
Organic adnexal tumors
Rationale  for  the  use  of  dynamic  contrast
enhanced  MRI  to  characterize  adnexal  tumors
Preoperative  characterization  of  adnexal  tumors  is  essen-
tial  in  order  to  plan  surgery.  The  distinction  between
benign,  borderline  and  malignant  tumors  is  important  in
order  to  decide  on  the  surgical  approach  (laparoscopy
versus  laparotomy)  and  the  type  of  surgery  (such  as  cys-
tectomy,  unilateral  salpingo-oophorectomy  or  hysterectomy
with  bilateral  salpingo-oophorectomy).  These  are  particu-
larly  important  factors  in  young  women  when  the  challenge
is  to  preserve  fertility  whilst  offering  optimal  treatment.
It  is  also  an  important  factor  in  post-menopausal  patients
in  whom  surgery  causes  many  co-morbidities  and  for  whom
monitoring  via  imaging  may  be  offered.  With  epithelial
tumors,  it  is  also  useful  for  the  surgeon  to  know  whether
he/she  is  dealing  with  a  serous  or  mucinous  tumor  (as  a  com-
plementary  appendectomy  is  performed  in  the  latter  type).
The  main  technique  used  to  characterize  ovarian  masses
is  currently  endovaginal  ultrasound.  According  to  the  stud-
ies,  the  diagnostic  accuracy  of  this  investigation  varies
greatly.  Endovaginal  ultrasound  is  a  very  good  method  to
characterize  non-complex  small  masses.  The  risk  of  malig-
nancy  is  extremely  low  (0.3%)  for  an  anechogenic  unilocular
cyst  under  50  mm  in  size  on  ultrasound.  There  is  there-
fore  no  point  in  performing  other  imaging  investigations
in  this  situation.  However,  for  larger  masses  (over  50  mm
in  size)  or  with  ‘‘complex’’  masses  (non-unilocular  or  non-
anechogenic),  this  technique,  even  when  combined  with
Doppler  ultrasound,  has  been  shown  to  have  far  poorer  diag-
nostic  accuracy  (63%).
Some  authors  recommend  a  second-line  diagnostic
laparoscopy.  This  approach  is  debatable  as  laparoscopy  has
a  poor  positive  predictive  value  (34.7%)  because  of  the  large
number  of  false  positives  due  to  the  inability  to  distinguish
laparoscopically  between  a  benign  and  malignant  growth.
Several  studies  have  shown  sectional  imaging  techniques
(MRI  or  CT)  to  have  added  value  in  characterizing  ‘‘complex
or  equivocal’’  masses  on  endovaginal  ultrasound  [11]. MRI
has  been  shown  to  be  considerably  superior  to  CT  in  char-
acterizing  tumors  in  this  situation  because  of  its  excellent
tissue  contrast  [11].  Pelvic  MRI  also  helps  in  diagnosing
pseudotumors,  including  subacute  or  chronic  Fallopian  tube
diseases  such  as  pelvic  infection  or  adnexal  torsion.
Gadolinium-enhanced  investigations  can  identify  the
presence  of  a  tissue  component  within  the  tumor,  which
is  classically  deemed  to  be  a  predictive  factor  for
malignancy.  This  tissue  component  includes  vegetations,
thickens  irregular  septa  and  a  solid  portion  [12],  although
b
c
e
a1295
his  can  also  be  seen  in  many  benign  tumors.  It  is  there-
ore  essential  to  optimize  the  characterization  of  this  tissue
omponent.  Some  MRI  appearances  have  a  diagnostic  accu-
acy  of  over  90%  in  favor  of  benign  disease.  These  include
hading  (an  appearance  indicating  a  T2  hypointensity  of  a
peciﬁc  cystic  lesion  in  an  ovarian  endometrioma)  or  fat
ithin  the  tumor  (which  is  almost  solely  speciﬁc  to  mature
ystic  teratoma).  In  these  two  situations,  conventional  MRI
s  sufﬁcient  to  characterize  the  tissue  although  in  popula-
ions  other  than  those  with  these  two  types  of  tumor,  the
ther  classical  signs  of  malignancy  (bilateral  disease,  pre-
ominantly  solid  mass,  thick  irregular  septa,  vegetations,  a
olid  portion,  lymphadenopathy  and  ascites)  all  have  a  diag-
ostic  accuracy  of  under  75%.  Additional  sequences  such  as
ynamic  contrast  enhanced  MRI  or  diffusion  MRI  are  needed
or  this  type  of  tumor  to  improve  preoperative  characteri-
ation  of  the  lesions.
haracterization  of  adnexal  tumors
he  tumor  tissue  forming  the  solid  component  of  adnexal
umors  has  different  microvascular  features  depending
n  whether  it  is  benign  or  malignant  and  invasive.  The
icrovasculature  of  malignant  tumors  over-expresses  one
f  the  VEGF  receptors  (VEGFR-2)  and  has  defective  pericyte
overage.  This  immaturity  of  the  microvasculature  wall  is
een  on  dynamic  contrast  enhanced  MRI  as  a  greater  max-
mum  enhancement  gradient  than  in  benign  tumors  [13].
ynamic  contrast  enhanced  MRI  can  therefore  play  a  major
ole  in  characterizing  tumor  tissue  [14].  Three  types  of  early
nhancement  curve  (less  than  2  min)  are  seen,  using  the
djacent  myometrium  as  the  internal  reference,  and  cor-
elate  with  histological  type:  curve  type  1,  the  ‘‘benign’’
urve  describes  a gradual  enhancement  curve,  curve  type
 describes  an  earlier  enhancement  curve  but  one  which  is
lso  later  than  the  myometrial  curve  with  a  plateau  effect
nd  the  type  3  curve  which  is  speciﬁc  to  invasive  malignant
umors,  describes  a  curve  which  is  shifted  to  earlier  than
hat  of  the  myometrium  [15].
Dynamic  contrast  enhanced  MRI  can  also  be  useful
o  characterize  solid  pelvic  tumors.  The  most  common
f  these  are  the  subserosal  leiomyoma  and  the  ovarian
broma  which  can  be  difﬁcult  to  distinguish  on  morpho-
ogical  criteria.  These  two  tumors  usually  present  as  a
2-weighted  hypointense  mass  with  regular  outlines.  They
ay  be  homogeneous  or  heterogeneous  and  their  size  is
on-speciﬁc.  Dynamic  contrast  enhanced  MRI  can  easily  dis-
inguish  between  these  two  types  of  tumors  by  showing  a
arallel  dynamic  curve  to  that  of  the  adjacent  myometrium
n  the  subserosal  myomas  unlike  the  ovarian  ﬁbromas  which
ave  low  late  enhancement  [16].
Finally,  adding  functional  perfusion  and  diffusion
equences  to  a conventional  protocol  can  signiﬁcantly
mprove  the  diagnostic  accuracy  of  pelvic  MRI  to  charac-
erize  complex  adnexal  masses.  Perfusion  and  diffusion
equences  improve  the  radiologist’s  diagnostic  accuracy
y  15  and  25%  respectively  with  a  particularly  signiﬁcant
eneﬁt  in  reclassifying  tumors  which  would  otherwise  have
een  diagnosed  as  malignant  according  to  conventional  MRI
riteria  as  benign  [1].  This  has  been  shown  regardless  of  the
xperience  of  the  person  interpreting  the  MRI.  Combining
ll  of  these  factors  in  a  multivariate  model  can  increase
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iagnostic  accuracy  by  96%,  making  pelvic  MRI  a  reliable
nd  useful  and  appropriate  tool  in  the  management  of
dnexal  masses.  This  is  an  essential  clinical  practice  point
n  patients  of  childbearing  age  as  it  enables  us  to  safely
ffer  them  conservative  surgery  and  preserve  their  fertility.
t  can  also  help  to  reduce  the  number  of  unnecessary
urgical  procedures  which  are  a  source  of  morbidity,  in
ost-menopausal  patients.
One  more  recent  study  has  examined  the  value  of  quan-
itative  parameters  obtained  from  compartmental  modeling
n  characterizing  adnexal  tumors  [17].  This  study  was  per-
ormed  on  54  patients  and  demonstrated  the  utility  of
icrocirculatory  parameters  such  as  tissue  perfusion  (FT),
he  blood  volume  fraction  (Vb),  interstitial  volume  and  area
nder  the  curve  (rAUC)  to  distinguish  benign  from  malignant
umors.  In  addition,  with  malignant  tumors,  microcircula-
ory  parameters  can  distinguish  malignant  tumors  associated
ith  peritoneal  carcinomatosis  (found  upon  surgical  explo-
ation)  from  those  not  associated  with  carcinomatosis.  This
s  useful  information  as  no  morphological  imaging  technique
ffers  particularly  good  diagnostic  accuracy  to  detect  seeds
f  peritoneal  carcinomatosis.  Yet,  this  is  an  essential  pre-
perative  ﬁnding  to  enable  the  oncologist  to  decide  on  the
est  treatment  option,  particularly  for  advanced  stages  IIIC
nd  IV  tumors  (neoadjuvant  chemotherapy  versus  ﬁrst-line
urgery).
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igure 3. Images from MR and CT showing a T2-weighted axial seque
1-weighted sequence after gadolinium (d). Dynamic section after injec
o that of the adjacent healthy external myometrium (h).I.  Thomassin-Naggara  et  al.
onclusion
n  conclusion,  perfusion  imaging  has  become  a  standard
ool  in  many  female  pelvic  diseases  and  is  now  an  essential
equence,  unavoidable  in  many  cases.
TAKE-HOME  MESSAGES
The  main  uses  of  perfusion  sequences  in  the  primary
MRI  indications  in  female  pelvic  disease  are:
• in  cervical  cancer:  detection  of  initial  small  tumors
and  distinction  between  post-radiation  ﬁbrosis  and
recurrence  of  tumor;
• in  endometrial  cancer:  identiﬁcation  of  cervical
invasion;
• for  pelvic  masses:  distinction  between  ovarian
ﬁbroma  and  ﬁbroid  and  characterization  of  complex
adnexal  tumors  (benign,  borderline,  invasive).
linical case reporthis  28-year-old  woman  was  referred  for  a  pelvic  MRI  to
haracterize  a  pelvic  mass  discovered  incidentally  during  an
ltrasound  performed  for  abdominal  pain  (Fig.  3).
nce (a), a diffusion sequence (b), CT without injection (c) and a
tion (e, f, g). Perfusion curve comparing enhancement of the mass
MR  perfusion  for  pelvic  female  imaging  
R
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[Figure 4. CT shows largish coarse central calciﬁcations.
Questions
1.  Describe  the  abnormalities  seen  on  morphologicalMRI.
2.  Describe  the  abnormalities  seen  on  perfusion
MRI.
3.  Describe  the  abnormalities  seen  on  diffusion  MRI.
4.  What  is  the  most  likely  diagnosis  and  how  are  the
differential  diagnose  excluded?
(a)  Fibrothecoma
(b)  Brenner’s  tumor
(c)  Ovarian  metastases
(d)  Broad  ligament  ﬁbroid
(e)  Cystadenocarcinoma
Answers
1.  This  is  a  solid  hypervascularized  lateral  uterine  mass
which  is  heterogeneous  on  a  T2-weighted  sequence.
It  is  not  possible  to  establish  whether  it  originates
from  the  uterus  or  adnexae,  as  the  normal  ipsilat-
eral  ovary  cannot  be  seen  despite  the  patient’s  young
age.
2.  The  perfusion  curves  for  the  mass  show  that  it
enhances  in  parallel  with  the  adjacent  healthy  myometrium,
following  a  type  2  curve  (which  makes  a  ﬁbrothecoma
unlikely,  as  this  classically  enhances  slowly  and  gradually,
following  a  type  1  curve).
3.  In  addition,  this  solid  mass  has  no  hyperintensity
on  a  diffusion  sequence,  which  is  strong  diagnos-
tic  evidence  in  favor  of  benign  disease  and  excludes
the  diagnoses  of  cystadenocarcinoma  and  an  ovarian
metastasis.
4.  Therefore,  only  the  diagnostic  possibilities  of  a Bren-
ner’s  tumor  and  broad  ligament  ﬁbroid  remain.  The  features
of  the  perfusion  curve  which  follows  in  parallel  to  the  exter-
nal  myometrial  curve  variations,  point  towards  a  ﬁbroid,
which  was  conﬁrmed  surgically.
The  patient  had  had  a  CT  (Fig.  4)  which  can  be  useful
at  diagnosis  by  showing  largish  coarse  central  calciﬁca-
tions.Disclosure of interest
The  authors  declare  that  they  have  no  conﬂicts  of  interest
concerning  this  article.
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